Talking openly with your doctor is one of the best ways to feel good about your breast cancer treatment decisions and your care. Learn more here.| Susan G. Komen®
CDK4/6 Inhibitors for Metastatic Breast Cancer CDK4 and CDK6 are enzymes important in cell division. CDK4/6 inhibitors are drugs designed to interrupt the growth of cancer cells. CDK4/6 inhibitors are used in combination with hormone therapy to treat some hormone receptor-positive breast cancers. The CDK4/6 inhibitors FDA-approved for metastatic breast cancer treatment are: Drug name […]| Susan G. Komen®
Hormone Therapy for Metastatic Breast Cancer Watch Susan G. Komen®’s January 2024 MBC Impact Series, Metastatic Breast Cancer and Estrogen Receptor-Positive Breast Cancer. What is hormone therapy? Estrogen and progesterone are female hormones produced in the body. Some breast cancer cells need estrogen and/or progesterone to grow. When these hormones attach to special proteins called […]| Susan G. Komen®
Monitoring Metastatic Breast Cancer Metastatic breast cancer (also called stage IV or advanced breast cancer) is breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body (most often the bones, lungs, liver or brain). Metastatic breast cancer can respond to many different drug therapies. This means the […]| Susan G. Komen®